LifeStance Health Group, Inc. 8-K

What Happened
LifeStance Health Group, Inc. (LFST) filed a Form 8-K (Item 5.02) on March 11, 2026 reporting that, effective March 10, 2026, Lisa Miller (age 52) was promoted to Chief Operating Officer and Principal Operating Officer. Ms. Miller previously served as Executive Vice President, Practice Operations (Feb 2024–Mar 10, 2026) and Senior Vice President, Practice Operations (Sep 2022–Feb 2024). Prior to LifeStance, she was COO and Interim CEO of Invo Healthcare (Sep 2020–Apr 2022). Ms. Miller holds an M.S. in Neuroscience and an MBA from Columbia Business School.

Key Details

• Effective date: March 10, 2026 (the “Start Date”); disclosed in Form 8-K filed Mar 11, 2026.
• Base salary: $485,000 per year.
• Annual bonus: starting for calendar year 2026, a target equal to 85% of base salary, payable based on performance objectives.
• Equity award: target grant date value of approximately $1,500,000 under the Company’s 2021 Equity Incentive Plan, split between time-based restricted stock units (vesting in equal installments on each of the first three anniversaries) and performance-based restricted stock units (vesting in equal installments over three years subject to achievement of performance targets).

Why It Matters
The filing documents an executive leadership change and the specific compensation terms for the new COO—salary, bonus target, and a sizable equity award with multi-year vesting. These are material disclosures for investors tracking management stability, corporate governance, and potential future equity dilution or compensation expense tied to incentive awards.